Contact us


Prof. Dr. med. Heinz Wiendl (Münster)
University Hospital Muenster
Department of Neurology
Albert-Schweizer-Campus 1, Geb. A1, 48149 Münster
Tel: +49 251 83-46811
Fax: +49 251 83-46812
Email: heinz.wiendl@ukmuenster.de

 

 

Prof. Dr. Frauke ZippUniv-Prof. Dr. Frauke Zipp (rmn2)
University Medical Center of the Johannes-Gutenberg University, Mainz
Neurology Department
Langenbeckstr. 1
55131 Mainz
Tel.: +49 6131 17-7156
Email: frauke.zipp@unimedizin-mainz.de

 

 

Prof. Dr. med. Martin kerschensteiner (Munich)
Institute of Clinical Neuroimmunology
Ludwig Maximilians University, Munich
Marchioninistr. 15
81337 München
Tel.: +49 89 70954780
Fax: +49 89 70954781
Email: martin.kerschensteiner@med.uni-muenchen.de

 

 

Dr. rer. nat Annika Michaelis
University Hospital Muenster
Department of Neurology
Albert-Schweizer-Campus 1, Geb. A1
48149 Münster
Email: annikakathrin.michaelis@ukmuenster.de

 

News

Fri, 29/10/2021
Seminar on DFG’s equal opportunities measures
On 7 December 2021 and 16 February 2022, the DFG will offer an online information event for researchers and science managers who would like to gain an overview of the DFG’s equal opportunities measures in the various funding procedures. Date I: 7 December 2021, 1:00 – 2:30 p.m. Direct link to Webex: https://dfg.webex.com Date II: […]...more
Mon, 09/08/2021
Dietary conjugated linoleic acid links reduced intestinal inflammation to amelioration of CNS autoimmunity
A close interaction between gut immune responses and distant organ-specific autoimmunity including the CNS in multiple sclerosis has been established in recent years. This so-called gut-CNS axis can be shaped by dietary factors, either directly or via indirect modulation of the gut microbiome and its metabolites. Here, SFB 128 PI Luisa Klotz and colleagues report […]...more
Thu, 28/01/2021
BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Science
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced the publication of preclinical data on its novel mRNA vaccine approach against autoimmune diseases in the peer-reviewed journal Science. The publication titled “A non-inflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis” co-authored by SFB principal investigator Ari Waisman summarizes the findings on the disease-suppressing effects […]...more